Navigation Links
Study shows no evidence of a mortality benefit to PSA screening
Date:1/6/2012

Men enrolled in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial had no evidence of a mortality benefit compared to a control group of men undergoing usual care, according to a study published online Jan. 6 in the Journal of the National Cancer Institute.

The Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) Trial is a multi-center, two-arm trial, which began enrollment in November 1993 with follow-up through December 2009, and was designed to evaluate the effect of screening on these specific cancers. The enrollees were aged 55-74 and had no previous personal history of these cancers. Men in the intervention arm underwent annual PSA testing for six years and annual digital rectal examination for four years, while those in the control arm received their usual medical care, which for some men included screening. A previous report of PLCO results through ten years was criticized for being too short of a follow-up period.

To determine longer-range outcomes among the men enrolled in PLCO, Gerald L. Andriole, M.D., of Washington University School of Medicine in St. Louis, and colleagues, examined outcomes of the men through 13 years. The researchers found a statistically significant 12% relative increase in the incidence rate of prostate cancer, and a non-statistically significant decrease in the incidence of high-grade prostate cancer in the intervention arm compared to the control arm, but no difference in mortality between the two arms. In addition, there was no apparent differential effect of screening by age category, pre-trial PSA testing, or co-morbidity.

The authors write, "Improvements in prostate cancer treatment are probably at least in part responsible for declining prostate cancer mortality rates. Even if life is only prolonged by therapy, the opportunities for competing causes of death increase, especially among older men."

The authors also point out that of the 425
'/>"/>

Contact: Zachary Rathner
Zachary.Rathner@oup.com
301-841-1286
Journal of the National Cancer Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study Offers Clues to Why Some Dont Benefit From Asthma Drugs
2. Mice Exposed to Smoke Helped by Blood Pressure Drug: Study
3. Global Study Finds Drug Abuse Highest in Richer Nations
4. Diabetes Care Thwarted by Unstable Health Insurance: Study
5. Moderate red wine drinking may help cut womens breast cancer risk, Cedars-Sinai study shows
6. Mental Decline Can Start at 45, Study Finds
7. Study finds statin costs 400 percent higher in US compared to UK
8. Drug Eases Gout Flare-ups in Some Patients: Study
9. Study Reveals Whos More Prone to Be a Mean Drunk
10. Kaiser Permanente study finds continuous health coverage essential for patients managing diabetes
11. Safety-First Playgrounds Linked to Bored, Inactive Kids: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2015)... ProText Kinetic 2 is a set of typography ... X. ProText Kinetic 2 features 40 animation presets ... X . Easily create interactive text videos without having ... Kinetic 2. , Using ProText Kinetic is as easy as ... presets in the FCPX timeline. Playback the default animation ...
(Date:5/2/2015)... 2015 Kare Visits LLC. launched in Chicago ... caregivers. Kare Visits offers relief for caregivers by visiting ... According to the Caregiver Action Network, eight in ... 20 hours a week caring for an elderly or disabled ... hire a nurse, a caregiver is now empowered to schedule ...
(Date:5/1/2015)... May 02, 2015 The Venetian on ... http://www.thevenetiangracebay.com , and it is elegant and sophisticated, ... white and attractive turquoise hues of Grace Bay Beach. ... seven percent of leisure travelers used their smartphones throughout ... were used in the planning and researching and continued ...
(Date:5/1/2015)... Costa Mesa, CA (PRWEB) May 01, 2015 ... sponsor at the Cerner Southeast Regional User Group (RUG) ... 2015. The Cerner Southeast Regional User Group Conference provides ... access to vendors who support all aspects of electronic ... innovative use of Cerner software applications. , In addition ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 The Quail Creek ... American Cancer Society. Since 2001, the Quail Creek Relay team ... team host events throughout the year, including their biggest event, ... Golf Ball Drop. , Quail Creek Relay for Life ... battling cancer. Kate Kerwin, fitness director, states, “I was hooked ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2
... Federation of Clinical Immunology Services meeting in San Diego ... the disabling inflammatory condition. ,Dr. Gregersen ... in his laboratory at the Robert S. Boas Center ... for Medical Research in Manhasset, NY and more than ...
... then the "medical condition" on whose basis Paris Hilton was ... inside a day later, was not depression, but a sexually ... World paper, the heiress has contracted an STI, and it ... the Los Angeles' Century Regional Detention Center decided to remove ...
... researchers at San Francisco VA Medical Center (SFVAMC) has found ... can predict people who may develop dementia within six years. ... furnishes 87 per cent accurate results, is a 14-point index ... ,Lead study author Dr. Deborah E. Barnes, a mental ...
... scans and tests of reading skills when taken together are ... ,The study was conducted by a team of ... School of Medicine. , ,As part of the ... 12, who were identified as struggling readers, ran for a ...
... A new mechanistic description of how tumor cells migrate ... tumor metastasis has been developed by a swiss-based ... for developing anti-metastasis therapies. ,Scientists know that ... dont understand the details of how this deadly migration ...
... estimated 11,000 Filipino nurses re-sat their examinations Monday after ... their results, an official said Monday . Lawyers hired ... Schools (CGFNS) acted as observers at examination centres in ... Arturo Brion said the graduates were re-taking the examinations ...
Cached Medicine News:Health News:New Developments in Rheumatoid Arthritis 2Health News:New Developments in Rheumatoid Arthritis 3Health News:Paris' 'medical Condition' is a Sexually Transmitted Infection 2Health News:Simple Test to Predict People Who may Develop Dementia Within Six Years 2Health News:Combination of Brain Scans, Reading Skill Tests can Predict Kids Reading Problems 2Health News:Developing Antimetastasis Therapy- An Early Stage of Tumor Control. 2Health News:Philippine Nurses Re-sit Scandal-tainted Exams 2
(Date:5/1/2015)...  Boston Scientific Corporation (NYSE: BSX ) is ... long-term growth strategies at a meeting with the investment ... . President and Chief Executive Officer Mike Mahoney ... to bring forward meaningful innovation to transform patient care, ... value. "We are focused on addressing ...
(Date:5/1/2015)... 2015 Cambrex Corporation (NYSE: CBM ) reports ... Highlights , Sales increased 18% compared ... foreign currency impact, driven by Innovator products and Controlled Substances. ... in the first quarter of 2014. , GAAP Diluted ... first quarter last year and Adjusted Diluted EPS was $0.29 ...
(Date:4/30/2015)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider ... today announced results for its first quarter ended March ... first quarter of 2015 was $116.2 million, up $14.5 ... and down $5.3 million or 4.4% from the fourth ... income as reported in accordance with U.S. generally accepted ...
Breaking Medicine Technology:Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 2Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 3Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 5Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 6Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 7Cambrex Reports First Quarter 2015 Financial Results 2Cambrex Reports First Quarter 2015 Financial Results 3Cambrex Reports First Quarter 2015 Financial Results 4Cambrex Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 6Cambrex Reports First Quarter 2015 Financial Results 7Cambrex Reports First Quarter 2015 Financial Results 8Cambrex Reports First Quarter 2015 Financial Results 9Cambrex Reports First Quarter 2015 Financial Results 10Cambrex Reports First Quarter 2015 Financial Results 11Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20
... Dec. 20, 2011  Advocates working with the disability and ... Senators and House members to help stop a Medicare ... wheelchairs prescribed by their physicians. Seven ... Medicare and Medicaid Services (CMS) for a prepayment review ...
... OSAKA, Japan, Dec. 20, 2011 Takeda Pharmaceutical ... Pharmaceuticals North America, Inc., announced today that the ... (azilsartan medoxomil and chlorthalidone) for the treatment of ... is the only fixed-dose therapy in the U.S. ...
Cached Medicine Technology:Michigan Seniors and Disabled Population Face Restricted Access to Power Wheelchairs Unless Congress Stops New Medicare Program 2Michigan Seniors and Disabled Population Face Restricted Access to Power Wheelchairs Unless Congress Stops New Medicare Program 3Michigan Seniors and Disabled Population Face Restricted Access to Power Wheelchairs Unless Congress Stops New Medicare Program 4FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension 2FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension 3FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension 4FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension 5FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension 6FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension 7
... Finnpipette Focus multichannel pipettes ... of reagents into microplates, ... 0.1-10 l volumes. The ... Finnpipette Focus multichannels, combined ...
... Research pro Electronic Pipette is ideal for ... Its easy-to-follow display, ergonomically-placed operating buttons, and ... reverse pipetting and diluting make this a ... functions of a manual pipette without any ...
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
... best value in high performance electronic pipetting!, ... design reduce hand fatigue and strain , ... ejector , Color coding for easy volume ... greater performance use Hamilton AdvanTip Low Retention ...
Medicine Products: